DuPont focusing on "nutraceuticals" category to help boost life sciences business.
This article was originally published in The Tan Sheet
Executive Summary
DUPONT ENTRY INTO "NUTRACEUTICALS" CATEGORY is part of a "three-fold" strategy the company is taking to spur growth in its life sciences division, DuPont Exec VP Kurt Landgraf told securities analysts during a teleconference May 11. In addition to boosting its pharmaceuticals and agriculture businesses, DuPont plans to focus on its nutraceuticals enterprise as the company pushes to generate higher life sciences sales and earnings.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning